Charles A. Stanley, MD, founding medical director of the Congenital Hyperinsulinism (HI) Center and an internationally renowned pioneer in HI research, received the Judson J. Van Wyk Prize, the most prestigious award given by the Pediatric Endocrine Society.
Dr. Stanley’s research has helped define the various types of HI. Even before the center was created in 1999, he pioneered best practices for diagnosis and treatment of congenital HI. Research into the genetic causes of HI is an area he is particularly passionate about because it drives the choice for the most appropriate treatment. He also led the creation of the Food and Drug Administration-approved study that uses 18F-DOPA PET scans to identify the location of focal lesions, which has led to more than 150 children being cured.
Featured in this article
Specialties & Programs
Charles A. Stanley, MD, founding medical director of the Congenital Hyperinsulinism (HI) Center and an internationally renowned pioneer in HI research, received the Judson J. Van Wyk Prize, the most prestigious award given by the Pediatric Endocrine Society.
Dr. Stanley’s research has helped define the various types of HI. Even before the center was created in 1999, he pioneered best practices for diagnosis and treatment of congenital HI. Research into the genetic causes of HI is an area he is particularly passionate about because it drives the choice for the most appropriate treatment. He also led the creation of the Food and Drug Administration-approved study that uses 18F-DOPA PET scans to identify the location of focal lesions, which has led to more than 150 children being cured.
Contact us
Congenital Hyperinsulinism Center